Week 1; Basics Flashcards
What are the nursing responsibilities of pharmacology?
Administering drugs, assessing drug effects, intervening to make the drug regimen more tolerable, Providing teaching about drugs and drug regimens, monitor the overall patient care plan to prevent medication errors, must be knowledgeable about changing landscape of medical treatment and rely on up-to-date and comprehensive drug and treatment guidelines.
Chemical name; generic name; trade name
- The name that reflects the chemical structure of a drug; 2.Name given by the United States adopted name council; 3.The drug has registered trademark; use of the name restricted by the drug’s owner
Phase I studies
Uses human volunteers to test the drugs. These studies are more tightly controlled than preclinical trials and are performed by specially trained clinical investigators. At the end of phase I studies, many chemicals are dropped from the process for the following reasons: they cause unacceptable adverse effects, they are highly teratogenic, they are too toxic, they lack evidence of potential therapeutic effect in humans
Phase II studies
Allows clinical investigators to try out the drug in patients who have the disease that the drug is designed to treat; performed at various sites across the country and are monitored by representatives of the pharmaceutical company studying the drug. May be removed from study because: It is less effective than anticipated, it is too toxic when used with patients, it produces unacceptable adverse effects, it has a low benefit-to risk ratio, meaning that the therapeutic benefit does not outweigh the risk of potential adverse effects.
Phase III studies
Involves the drug in a vast clinical market. Prescribers are informed of all the known reactions to the drug and precautions required for its Sade use. Prescribers observe patients very closely, monitoring them for an adverse effects. A drug that produces unacceptable adverse effects or unforeseen reactions in usually remove from further study by the drug company.
DEA schedule I drugs
Highest abuse potential (heroin, LSD, Marijuana, psilocybin); no accepted use for medicine, limited use for research purposes
DEA schedule II drugs
High abuse potential; morphine, PCP, cocaine; accepted use with restrictions
Pharmacodynamics
Study of what the drug does to the body
Pharmacokinetics
The study of what the body does to the drug; Absorption, distribution, ,metabolism, excretion
Pharmaceutics
The study of how various drug forms influence pharmacokinetic and pharmacodynamic activities
Pharmacotherapeutics
The use of drugs and the clinical indications for drugs to prevent and treat disease
In what ways do drugs work in the body
Replaces or act as a substitute for missing chemicals, to increase or stimulate cellular activities, to depress or slow cellular activities, to interfere with the functioning of foreign cells
Absorption
The rate at which a drug leaves its site of administration and the extent to which absorption occurs
Bioavailability
enough available drug to be absorbed from the body
Bioequivalent
establishes that the generic drugs have the same absorption and desired effects are the same as the trade drug
actors that affect absorption
Administration route of the drug, food or fluids administered with the drug, food or fluids administered with the drug, dosage formulation, status of the absorptive surface, rate or blood flow to the small intestine, acidity of the stomach, status of GI motility
Routes of admin
A drugs route of administration affects the rate and extent of absorption of the drug
enteral, parenteral, topical
Enteral
Absorbed through the oral or gastric mucosa; oral, sublingual, buccal, rectal
First pass effect
The metabolism of a drug and its passage from the liver into the circulation; the liver has a high metabolism rate which leads to a low or less therapeutic effect
Routes that bypass the liver
sublingual, buccal, rectal, intravenous, intranasal, transdermal, vaginal, intramuscular, subcutaneous, inhalation
Parental route
intravenous, intramuscular, subcutaneous, intradermal, intrathecal, intraarticular
Topical route
skin, eyes, ears, nose, lungs, vagina